Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma

<div>The K-M analysis of the 10 immune-related genes used to construct the immune-related risk signature for BLCA, including RBP7, PDGFRA, AHNAK, RAC3, IGF1, AGTR1, SLIT2, OAS1, MMP9, and OLR1.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma 